Under Frazier’s leadership during the federal government shutdown, Kenilworth-based drug giant Merck & Co. Inc. delivered lifesaving medicines and vaccines as well as long-term and sustainable value to its multiple stakeholders.
Frazier joined Merck in 1992 as vice president, general counsel and secretary of the company’s joint venture with Astra AB. He became vice president of public affairs in 1994, assistant general counsel in 1997 and general counsel in 1999. From 2007 to 2010, he served as president of Global Human Health, Merck’s sales and marketing division.
In 2010, Frazier became company president and he was appointed chairman and chief executive officer in 2011. He has increased Merck’s investment in research, including early research, while refocusing the organization on the launch and growth of key products that benefit society. Frazier has also led the formation of philanthropic and other initiatives that build on Merck’s 125-year plus legacy.